Crispr Therapeutics

Major U.S. indices ended in the green on Tuesday, with the Dow gaining nearly 124 points or 0.4% to 33,052.87. The S&P 500 and the Nasdaq indices also ended the day in positive territory. The S&P rose 0.65% to 4,193.80, while the Nasdaq rose 0.48% to 12,851.24. These are the top stocks that...

On Monday, Cathie Wood-led Ark Invest made a series of trades, with a significant purchase of shares in Block Inc (NYSE:SQ) standing out. The Block Trade Ark Invest's acquisition of 18,574 shares of Block underscores Wood's confidence in the company led by Jack Dorsey. The trade, valued at $811,...

This weekend's Barron's cover story offers thoughts and stock picks from the latest Barron's Roundtable. Other featured articles examine the cutting edge in biotech stocks, an outlier bubble forecast and growing corporate political activism. Also, the prospects for a struggling...

This weekend's Barron's cover story looks at why pharmaceutical giants are making big bets on gene therapy. See which companies already have been snapped up and which ones may be the next targets. Other notable articles offer a look at the implications of the tax law and a retirement guide...

This weekend's Barron's cover story looks at why pharmaceutical giants are making big bets on gene therapy. Other featured articles examine problems with packaged food companies and which high-yield dividends are safest. Also, the prospects for a weight-loss products leader and a fashion...